Sabby Management Holds Stake in Amag Pharmaceuticals (AMAG); Citigroup Com New (C) Holder Cna Financial Cut Stake as Share Price Declined

May 19, 2018 - By Vivian Currie

Citigroup Inc. (NYSE:C) Logo

Hal Mintz increased its stake in Amag Pharmaceuticals Inc (AMAG) by 48.38% based on its latest 2017Q4 regulatory filing with the SEC. Sabby Management Llc bought 38,756 shares as the company’s stock rose 33.69% while stock markets declined. The hedge fund run by Hal Mintz held 118,864 shares of the health care company at the end of 2017Q4, valued at $1.58 million, up from 80,108 at the end of the previous reported quarter. Sabby Management Llc who had been investing in Amag Pharmaceuticals Inc for a number of months, seems to be bullish on the $846.15 million market cap company. It closed at $24.65 lastly. It is down 16.25% since May 19, 2017 and is downtrending. It has underperformed by 27.80% the S&P500.




Cna Financial Corp decreased its stake in Citigroup Inc Com New (C) by 2.24% based on its latest 2017Q4 regulatory filing with the SEC. Cna Financial Corp sold 4,595 shares as the company’s stock declined 9.55% with the market. The institutional investor held 200,641 shares of the major banks company at the end of 2017Q4, valued at $14.93 million, down from 205,236 at the end of the previous reported quarter. Cna Financial Corp who had been investing in Citigroup Inc Com New for a number of months, seems to be less bullish one the $178.39B market cap company. The stock decreased 2.24% or $1.6 during the last trading session, reaching $69.96. About 16.16M shares traded. Citigroup Inc. (NYSE:C) has risen 17.06% since May 19, 2017 and is uptrending. It has outperformed by 5.51% the S&P500.

Sabby Management Llc, which manages about $835.79M and $1.08B US Long portfolio, decreased its stake in Gw Pharmaceuticals Plc (Put) by 796 shares to 353 shares, valued at $4.66 million in 2017Q4, according to the filing. It also reduced its holding in Zogenix Inc (Call) by 1,775 shares in the quarter, leaving it with 3,090 shares, and cut its stake in Vertex Pharmaceuticals Inc (Put).

More notable recent AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) news were published by: Benzinga.com which released: “Benzinga’s Daily Biotech Pulse: ARMO Skyrockets On Eli Lilly Deal, Akcea Meets FDA Panel, vTv Alzheimer’s Trial …” on May 10, 2018, also Nasdaq.com with their article: “AMAG Pharmaceuticals to Host First Quarter 2018 Financial Results Conference Call and Webcast on Thursday, May 3 …” published on April 26, 2018, Seekingalpha.com published: “AMAG Pharmaceuticals’ (AMAG) CEO William Heiden on Q1 2018 Results – Earnings Call Transcript” on May 03, 2018. More interesting news about AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) were released by: Nasdaq.com and their article: “AMAG Pharmaceuticals Announces First Quarter 2018 Financial Results and Raises Full Year Financial Guidance” published on May 03, 2018 as well as Benzinga.com‘s news article titled: “The Week Ahead In Biotech: PDUFA Dates, Clinical Trials, Merck And Pfizer Earnings On Tap” with publication date: April 29, 2018.

Since February 23, 2018, it had 0 insider purchases, and 1 insider sale for $16,016 activity.

Investors sentiment decreased to 0.9 in Q4 2017. Its down 0.54, from 1.44 in 2017Q3. It worsened, as 29 investors sold AMAG shares while 53 reduced holdings. 24 funds opened positions while 50 raised stakes. 37.72 million shares or 5.64% less from 39.98 million shares in 2017Q3 were reported. Renaissance Lc holds 851,900 shares. Arizona State Retirement holds 0.01% or 59,455 shares. Shell Asset invested in 8,541 shares or 0% of the stock. State Of Wisconsin Board reported 0% of its portfolio in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). 34,525 are held by State Teachers Retirement. 9,158 are held by Employees Retirement Association Of Colorado. Ameriprise Finance Inc stated it has 182,135 shares. Prelude Capital Mngmt Ltd Liability holds 0% of its portfolio in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) for 559 shares. Legal & General Group Inc Pcl owns 68,561 shares or 0% of their US portfolio. Int Gru stated it has 0% in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Goldman Sachs Gp holds 0% or 231,655 shares. Teachers Retirement Systems Of The State Of Kentucky owns 9,400 shares. Barclays Public Limited, a United Kingdom-based fund reported 27,812 shares. Guggenheim Capital Lc reported 0% of its portfolio in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Assetmark Incorporated owns 0% invested in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) for 13 shares.

Among 14 analysts covering AMAG Pharmaceuticals (NASDAQ:AMAG), 3 have Buy rating, 1 Sell and 10 Hold. Therefore 21% are positive. AMAG Pharmaceuticals had 47 analyst reports since August 18, 2015 according to SRatingsIntel. Cantor Fitzgerald maintained the shares of AMAG in report on Tuesday, February 27 with “Hold” rating. The rating was maintained by Morgan Stanley with “Overweight” on Friday, November 3. The stock has “Buy” rating by Jefferies on Friday, November 3. As per Friday, March 23, the company rating was maintained by FBR Capital. As per Tuesday, August 18, the company rating was initiated by Jefferies. On Thursday, September 3 the stock rating was reinitiated by Deutsche Bank with “Hold”. The rating was downgraded by Leerink Swann to “Mkt Perform” on Tuesday, January 10. Raymond James initiated the shares of AMAG in report on Tuesday, September 1 with “Outperform” rating. Cantor Fitzgerald maintained the shares of AMAG in report on Monday, July 24 with “Hold” rating. Jefferies maintained it with “Buy” rating and $45 target in Thursday, August 11 report.

More important recent Citigroup Inc. (NYSE:C) news were published by: Benzinga.com which released: “JPMorgan, HSBC, Citigroup, Early Warning Execs Talk Fintech Collaboration” on May 15, 2018, also Seekingalpha.com published article titled: “Why ValueAct Pounced On Citigroup”, Seekingalpha.com published: “Citigroup: Buy Now” on May 01, 2018. More interesting news about Citigroup Inc. (NYSE:C) was released by: Livetradingnews.com and their article: “Citigroup Inc. (NYSE:C) Heffx Technical Analysis” with publication date: May 17, 2018.

Investors sentiment decreased to 1.07 in Q4 2017. Its down 0.28, from 1.35 in 2017Q3. It turned negative, as 58 investors sold C shares while 480 reduced holdings. 123 funds opened positions while 450 raised stakes. 1.99 billion shares or 2.45% less from 2.04 billion shares in 2017Q3 were reported. Apg Asset Nv reported 8.10M shares. Skylands Capital Limited holds 142,650 shares. Tsp Management Gru Llc stated it has 6,300 shares or 0.21% of all its holdings. Stonehearth Mgmt Ltd owns 190 shares. Nuveen Asset Limited Liability Corporation invested in 912,050 shares. Tillar holds 31,107 shares. Franklin Resource Inc reported 0.88% in Citigroup Inc. (NYSE:C). Menta Ltd Liability owns 0.47% invested in Citigroup Inc. (NYSE:C) for 32,676 shares. Ballentine Partners Ltd reported 10,425 shares. Toth Fincl Advisory stated it has 50 shares or 0% of all its holdings. 10 holds 0.07% of its portfolio in Citigroup Inc. (NYSE:C) for 4,180 shares. Clearbridge Lc has invested 0.43% in Citigroup Inc. (NYSE:C). Aspen Investment Mngmt Incorporated reported 11,513 shares stake. Pictet National Bank & Trust Limited accumulated 30,959 shares or 0.68% of the stock. Cibc World Mkts owns 0.17% invested in Citigroup Inc. (NYSE:C) for 502,117 shares.

Cna Financial Corp, which manages about $415.58 million US Long portfolio, upped its stake in Universal Corp Va Com (NYSE:UVV) by 8,049 shares to 21,512 shares, valued at $1.13 million in 2017Q4, according to the filing. It also increased its holding in Hope Bancorp Inc Com by 16,913 shares in the quarter, for a total of 80,244 shares, and has risen its stake in Wells Fargo Co New Com (NYSE:WFC).

Among 40 analysts covering Citigroup Inc. (NYSE:C), 23 have Buy rating, 2 Sell and 15 Hold. Therefore 58% are positive. Citigroup Inc. had 125 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was upgraded by Portales Partners to “Sector Perform” on Thursday, January 7. Societe Generale downgraded the shares of C in report on Tuesday, September 13 to “Sell” rating. As per Monday, October 2, the company rating was maintained by Wells Fargo. Jefferies downgraded Citigroup Inc. (NYSE:C) on Monday, November 28 to “Hold” rating. Nomura maintained it with “Buy” rating and $78 target in Monday, July 17 report. The company was downgraded on Monday, September 21 by Iberia Capital Partners. On Wednesday, January 11 the stock rating was reinitiated by UBS with “Sell”. UBS maintained it with “Buy” rating and $62 target in Friday, October 16 report. The firm has “Buy” rating by Vining Sparks given on Friday, April 6. The firm has “Buy” rating by BMO Capital Markets given on Thursday, June 1.

Since February 27, 2018, it had 0 insider buys, and 6 selling transactions for $4.97 million activity. 7,000 shares valued at $536,410 were sold by Callahan Don on Wednesday, February 28. $263,126 worth of stock was sold by MURRAY JOSEPH MICHAEL on Tuesday, February 27. The insider Fraser Jane Nind sold $2.51M. On Tuesday, February 27 Hu W. Bradford sold $611,804 worth of Citigroup Inc. (NYSE:C) or 8,010 shares. Another trade for 7,000 shares valued at $542,920 was sold by Gerspach John C.

Analysts await Citigroup Inc. (NYSE:C) to report earnings on July, 13. They expect $1.57 EPS, up 23.62% or $0.30 from last year’s $1.27 per share. C’s profit will be $4.00 billion for 11.14 P/E if the $1.57 EPS becomes a reality. After $1.68 actual EPS reported by Citigroup Inc. for the previous quarter, Wall Street now forecasts -6.55% negative EPS growth.

Citigroup Inc. (NYSE:C) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.